
Lytham Partners
@lythamir
We are a full-service IR firm providing expertise & guidance to small-cap companies. Please read our disclaimer at lythampartners.com/disclaimer/.
ID: 301040848
http://www.lythampartners.com 18-05-2011 19:36:29
1,1K Tweet
446 Followers
320 Following

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA™ (gepirone) Extended-Release Tablets in the United States. Read more: lythamportal.com/aytu-biopharma… $AYTU Aytu_BioPharma


















